跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 22 条关于
“Gel4Med”
全部
22
临床试验
7
药物
1
机构
2
资讯
12
去年
Gel4Med's G4Derm Plus Shows Rapid Healing in Complex Diabetic Foot Ulcers with Novel Biomimetic Matrix Technology
10个月前
Galmed Reports Promising Triple-Drug Combination for Gastrointestinal Cancers
5个月前
Galmed Develops Brain-Penetrating Aramchol Formulation for Parkinson's Disease and Synucleinopathies
去年
Galmed Discovers Novel Blood Biomarkers for Aramchol, Expanding Therapeutic Potential Beyond MASH
9个月前
Galmed Secures Global Patent Protection for Aramchol-Rezdiffra Combination Therapy in MASH Treatment
去年
Galmed Reports Promising Results for Aramchol Meglumine Formulation in Phase 1 Bioavailability Study
去年
Galmed Pharmaceuticals Advances Novel Sublingual Semaglutide Formulation to Challenge Injectable GLP-1 Market
4个月前
Galmed Develops Brain-Penetrating ODF Formulation of SCD1 Inhibitor Aramchol for Parkinson's Disease
去年
Aramchol Shows Significant Anti-Fibrotic Effects in MASH Patients, Phase 3 Trial Results Published in Hepatology
4个月前
Tissue Dynamics and Galmed Partner to Develop Novel Cardiac Fibrosis Platform Using Human Organoids and AI
第 1 页,共 2 页
上一页
下一页